Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.5, ...

HealthEquity fell by 17.07 percent on Wednesday to end at $84.32 each after missing earnings estimates in its latest earnings performance ... are looking for an AI stock that is as promising ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value ...

The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th.

Despite its strong performance, HealthEquity faces several challenges ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

HealthEquity (HQY) stock dropped over 13% aftermarket trading ... Healthequity’s strong fundamentals and earnings performance, coupled with the pro-HSA political landscape, bolster her outlook.

On Tuesday, HealthEquity ... s overall financial and operational performance will keep improving once temporary extra costs subside. Price Action: HQY stock is down 18.9% at $82.46 at the last ...

HealthEquity, Inc. (NASDAQ:HQY) stock had a great 2024 ... Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether ...

HealthEquity HQY has faced a challenging start to 2025, with the stock plunging more than 13.1% year to date compared with the industry’s 1.5% and S&P 500 Index’s 9.2% decline, respectively. This ...

HealthEquity HQY has faced a challenging start to 2025, with the stock plunging more than ... investors should assess whether future revenue performance justifies the premium, especially given ...